Beibei Du
Impact in
- Modeling and Simulation top 5%
- COVID-19 epidemiological studies
-
- Cardiac electrophysiology and arrhythmias
- Chemotherapy-induced cardiotoxicity and mitigation
- Heart Failure Treatment and Management
- Cardiac Fibrosis and Remodeling
- Cardiac Arrhythmias and Treatments
Papers in
-
- Cardiac electrophysiology and arrhythmias 4
- Chemotherapy-induced cardiotoxicity and mitigation 3
- Acute Myocardial Infarction Research 2
- Cardiac Fibrosis and Remodeling 2
- Blood Pressure and Hypertension Studies 1
- Atrial Fibrillation Management and Outcomes 1
-
- COVID-19 Clinical Research Studies 4
- Co-authors
- Daoyuan Si (8 shared papers)Ping Chang Yang (12 shared papers)Kumaraswamy Nanthakumar (8 shared papers)Stéphane Massé (6 shared papers)Patrick F.H. Lai (6 shared papers)Mohammed Ali Azam (6 shared papers)Mengyuan Li (2 shared papers)Praloy Chakraborty (4 shared papers)
In The Last Decade
Beibei Du
28 papers receiving 345 citations
Peers
Comparison fields: 5 of 76
- Modeling and Simulation 45
- Cardiology and Cardiovascular Medicine 125
- Infectious Diseases 56
- Endocrinology, Diabetes and Metabolism 29
- Geriatrics and Gerontology 6
Countries citing papers authored by Beibei Du
This map shows the geographic impact of Beibei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beibei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beibei Du more than expected).
Fields of papers citing papers by Beibei Du
This network shows the impact of papers produced by Beibei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beibei Du. The network helps show where Beibei Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Beibei Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 79 | |
| 2 | 2020 | 50 | |
| 3 | 2021 | 41 | |
| 4 | 2017 | 25 | |
| 5 | 2015 | 22 | |
| 6 | 2020 | 20 | |
| 7 | 2023 | 16 | |
| 8 | 2021 | 12 | |
| 9 | 2020 | 11 | |
| 10 | 2021 | 10 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 8 | |
| 14 | 2022 | 8 | |
| 15 | 2021 | 5 | |
| 16 | 2024 | 5 | |
| 17 | 2024 | 5 | |
| 18 | 2025 | 5 | |
| 19 | 2013 | 2 | |
| 20 | Warfarin continuation vs interruption during procedures of cardiac rhythm devices: A Meta-analysis of randomized controlled trials. | 2016 | 2 |
About Beibei Du
Beibei Du is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases, Modeling and Simulation, Pathology and Forensic Medicine and Geriatrics and Gerontology, having authored 29 papers that have together received 356 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (4 papers), COVID-19 Clinical Research Studies (4 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Acute Myocardial Infarction Research (2 papers), COVID-19 epidemiological studies (2 papers), Cardiac Fibrosis and Remodeling (2 papers), Blood Pressure and Hypertension Studies (1 paper) and Atrial Fibrillation Management and Outcomes (1 paper). The work is most often cited by research in Modeling and Simulation (45 citations), Cardiology and Cardiovascular Medicine (125 citations), Infectious Diseases (56 citations), Endocrinology, Diabetes and Metabolism (29 citations) and Geriatrics and Gerontology (6 citations). Beibei Du has collaborated with scholars based in China, Canada and Japan. Frequent co-authors include Daoyuan Si, Ping Chang Yang, Kumaraswamy Nanthakumar, Stéphane Massé, Patrick F.H. Lai, Mohammed Ali Azam, Mengyuan Li, Praloy Chakraborty, Xiaosheng Wang and Yue Zhang. Their work appears in journals such as Frontiers in Pharmacology, BMC Cardiovascular Disorders, Medicine, Frontiers in Cardiovascular Medicine and The American Journal of the Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.